First Author / Year | Participants with any Adverse Event | Participants with any Serious Adverse Event | Participants withdrawing due to Adverse Events |
---|---|---|---|
Tsui (1993) [10] | 20/20 participants had weakness after BTX-A injection. 12/20 had pain at site of injection. |
None reported | None reported |
Cole (1995) [11] | 7/10 participants had muscle weakness with BTX-A. 2/10 had weakness with placebo. |
None reported | None reported |
Kruisdijk (2007) [12] | 18/20 participants had weakness in the hand with BTX-A. 2/19 participants reported hand weakness with placebo. |
None reported | None reported |